Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics

Int J Biochem Cell Biol. 2011 May;43(5):701-4. doi: 10.1016/j.biocel.2011.01.020. Epub 2011 Feb 2.

Abstract

It is well-known that cell cycle arrest and/or death play a pivotal role in tumor progression, which has drawn a rising attention for cancer biologists due to their complex and intricate relationships. In this review, we demonstrate the recent research on oridonin, an active diterpenoid with remarkable anti-proliferative activities, and then further explore its molecular mechanisms of cell cycle arrest, apoptosis, autophagy and their cross-talks in various cancer cells, which may provide a new perspective of oridonin as a candidate anti-neoplastic drug for future cancer therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Autophagy / drug effects*
  • Cell Cycle / drug effects*
  • Cell Line, Tumor
  • Diterpenes, Kaurane / chemistry
  • Diterpenes, Kaurane / pharmacology*
  • Diterpenes, Kaurane / therapeutic use
  • Drug Stability
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / pathology*

Substances

  • Diterpenes, Kaurane
  • oridonin